Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8529451 | European Journal of Pharmacology | 2018 | 8 Pages |
Abstract
3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors (statins) have an immuno-regulatory effect in addition to lowing-lipids. Accumulated evidence showed that the expressions of T cell immunoglobulin- and mucin-domain-containing molecule-3Â (Tim-3) on natural killer (NK) cells increased in atherosclerotic patients and animal models. In this study, 14 patients treated with rosuvastatin and 12 patients with atorvastatin for more than 3 months were included and 20 patients without statins treatment as control. Both statins treatment reduced the expressions of Tim-3 on NK cells and their subtypes, natural killer T (NKT) cells and CD3+ T cells, and increased the proportions of NKT cells among peripheral blood mononuclear cells, accompanied by the decreased levels of total cholesterol, low density lipoprotein, and increased ratios of high density lipoprotein to cholesterol. These may contribute to the functions of statins in the treatment of atherosclerosis.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Na Zhang, Min Zhang, Ru-Tao Liu, Peng Zhang, Chun-Lin Yang, Long-Tao Yue, Heng Li, Yong-Kang Li, Rui-Sheng Duan,